Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the history list.
    Difference
    0.1%
    Check dated 2026-03-19T19:22:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The new screenshot shows Revision: v3.4.3 in the history, replacing Revision: v3.4.2. This is a small metadata update documenting the latest version.
    Difference
    0.1%
    Check dated 2026-03-12T10:43:07.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The screenshots depict the same history page with only minor UI/organizational changes and a new version entry added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-18T18:32:34.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding lapse notice and the Revision: v3.4.1 note were removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:23:31.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status. Updated the revision tag from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:46:19.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The history page now includes a glossary display option and color-coded legends for additions and deletions, and revision notes have been updated from v3.3.4 to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-01-28T06:11:02.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.